The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats

HUANG Fang~; ZHANG Xiao-lu; TAO Ming-long

doi:10.13422/j.cnki.syfjx.2010.01.022

您当前的位置：

首页 >

文章列表页 >

The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats

更新时间：2024-09-23

- The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 1, Pages: 95-98(2010)
- 作者机构：
  
  上海中医药大学附属岳阳中西医结合医院肾内科
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.01.022
  CLC： R285.5
- Published：2010
- 稿件说明：
移动端阅览
[1]黄芳,张小鹿,陶明龙.益肾泻浊化瘀方治疗大鼠慢性肾功能衰竭的实验研究[J].中国实验方剂学杂志,2010,16(01):95-98.

HUANG Fang~, ZHANG Xiao-lu, TAO Ming-long. The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(1): 95-98.
[1]黄芳,张小鹿,陶明龙.益肾泻浊化瘀方治疗大鼠慢性肾功能衰竭的实验研究[J].中国实验方剂学杂志,2010,16(01):95-98. DOI： 10.13422/j.cnki.syfjx.2010.01.022.

HUANG Fang~, ZHANG Xiao-lu, TAO Ming-long. The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(1): 95-98. DOI： 10.13422/j.cnki.syfjx.2010.01.022.

摘要

目的:观察益肾泻浊化瘀方对慢性肾功能衰竭（CRF）大鼠肾脏的保护作用

并探讨其作用机理。方法:将大鼠随机分为中药益肾泻浊化瘀方组、西药依那普利组、模型组及假手术组

以5/6肾大部切除术建立慢性肾衰大鼠模型

检测各组治疗前后血尿素氮（BUN）、血肌酐（Cre）;血一氧化氮（NO）、内皮素（ET）、降钙素基因相关肽（CGRP）水平及肾组织病理改变。结果:治疗后中药组和西药组BUN、Cre均较模型组明显下降（P<0.01）

且中药组Cre下降幅度较西药组大（P<0.05）。模型组大鼠血ET、CGRP含量较假手术组显著升高（P<0.01）

中药、西药均能有效降低ET水平

与模型组比较分别为P<0.01和P<0.05

中药组血CGRP含量下降（P<0.05）。各组血NO水平无显著差异。模型组肾组织病理改变最严重

中药组较西药组病变程度轻。结论:益肾泻浊化瘀方能有效保护CRF大鼠肾功能

且疗效优于西药依那普利

可能与其降低CRF大鼠血ET水平

减轻受损肾脏的病理改变等有关。

Abstract

Objective:To investigate the effects of Yishen Xiezhuo Huayu Decoction on chronic renal failure（CRF） in model rats and explore its action mechanism.Methods: Rats were randomly divided into the traditional Chinese medicine（TCM） Yishen Xiezhuo Huayu Decoction group

the Western medicine enalapril maleate group

the model group and the sham group.The CRF model was induced by 5/6 subtotal nephrectomy in rats.The blood levels of urea nitrogen（BUN）

creatinine（Cre）

nitric oxide（NO）

endothelin（ET）

clacitonin gene-related peptide（CGRP） and pathological changes of residual kidney were detected.Results: Following treatment

the blood levels of BUN and Ser of both the TCM group and the Western medicine group significantly declined compared with those of the model group（P<0.01）;moreover

the decline in the TCM group was more remarkable than in the western medicine group（P<0.05）.Compared with the sham group

the blood levels of ET and CGRP of the model group significantly rose（P<0.01）.Both the drugs studied could effectively lower the blood level of ET and the decreasing extents were significant in both the TCM group（P<0.01） and the Western medicine group（P<0.05） when compared with the model group.The blood level of CGRP of the TCM group also declined（P<0.05）.There were no significant differences in the blood level of NO of each group.The most severe pathologic changes in renal tissue were observed in the model group and Yishen Xiezhuo Huayu Decoction could alleviate the changes more effectively than enalapril maleate.Conclusion: Yishen Xiezhuo Huayu Decoction can protect renal functions of CRF rats more effectively than enalapril maleate.The action mechanism of the TCM might include the down-regulation of the blood ET level

and the alleviation of pathologic changes of renal tissues.

关键词

Keywords

references

Views

123

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Experimental Study of Yishen Xiezhuo Huayu Decoction on Chronic Renal Failure in Model Rats

Experimental Study on Shuangshenling Granules in Treating Chronic Renal Failure

Effect of Hei Xiaoyaosan on Neuroinflammation and NLRP3/Caspase-1/GSDMD Signaling Pathway in APP/PS1 Mice

Effect of Longmu Piyan Prescription on Oxidative Stress in Atopic Dermatitis Mice

Mechanism of Modified Zhenwutang in Delaying Renal Interstitial Fibrosis in Chronic Renal Failure Based on Ang Ⅱ/AT1R/NOX4 Signaling Pathway

Related Author

HUANG Fang

ZHANG Xiao-lu

TAO Ming-long

ZHAO Xiao-xia

MA Tian-tian

ZHANG Yong-li

WU Xiang-jin

ZHOU Jun

Related Institution

Guizhou Health Vocational College

Zhengzhou TCM Hospital Affiliated to Henan University of Chinese Medicine

Xingtai Hospital of TCM

Qujing 69 Hospital，China RongTong Medical Healthcare Group Co.， Ltd.

Xichang Hospital of TCM，Xichang

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰